Chemical compound prevents cancer in lab

May 13, 2008

While researching new ways to stop the progression of cancer, researchers at the University of Oklahoma Health Sciences Center, have discovered a compound that has shown to prevent cancer in the laboratory. The research appears in the journal Gene Regulation and Systems Biology.

The compound, which still faces several rounds of clinical trials, successfully stopped normal cells from turning into cancer cells and inhibited the ability of tumors to grow and form blood vessels. If successful tests continue, researchers plan to create a daily pill that would be taken as a cancer preventive.

“This compound was effective against the 12 types of cancers that it was tested on,” said Doris Benbrook, Ph.D., principal investigator and researcher at the OU Cancer Institute. “Even more promising for health care is that it prevents the transformation of normal cells into cancer cells and is therefore now being developed by the National Cancer Institute as a cancer prevention drug.”

The synthetic compound, SHetA2, a Flex-Het drug, directly targets abnormalities in cancer cell components without damaging normal cells. The disruption causes cancer cells to die and keeps tumors from forming.

Flex-Hets or flexible heteroarotinoids are synthetic compounds that can change certain parts of a cell and affect its growth. Among the diseases and conditions being studied for treatment with Flex-Hets are polycystic kidney disease, kidney cancer and ovarian cancer.

Benbrook and her research team have patented the Flex-Het discovery and hope to start clinical trials for the compound within 5 years. If the compound is found to be safe, it would be developed into a pill to be taken daily like a multi-vitamin to prevent cancer.

The compound also could be used to prevent cancer from returning after traditional radiation and chemotherapy treatments, especially in cancers that are caught in later stages such as ovarian cancer where life expectancy can be as short as 6 months after treatment.

“It would be a significant advancement in health care if this pill is effective in preventing cancer, and we could avoid the severe toxicity and suffering that late stage cancer patients have to experience,” Benbrook said.

Source: University of Oklahoma

Explore further: New research leads to FDA approval of first drug to treat radiation sickness

Related Stories

Salt-tolerant herb rich in antioxidant compounds

May 19, 2015

Epidemiological studies have emphasised the importance of eating foods high in antioxidants to reduce the risk of developing cancer and cardiovascular disease, two leading causes of death worldwide. Inside ...

Organic nanoparticles, more lethal to tumours

May 18, 2015

Radiotherapy used in cancer treatment is a promising treatment method, albeit rather indiscriminate. Indeed, it affects neighbouring healthy tissues and tumours alike. Researchers have thus been exploring the possibilities ...

Exposing breast cancer using nanoscale polymers

May 13, 2015

Photoacoustic imaging is a ground-breaking technique for spotting tumors inside living cells with the help of light-absorbing compounds known as contrast agents. A*STAR researchers have now discovered a way ...

Many uses in researching quantum dots

May 04, 2015

It's easier to dissolve a sugar cube in a glass of water by crushing the cube first, because the numerous tiny particles cover more surface area in the water than the cube itself. In a way, the same principle applies to the ...

Recommended for you

Vortex device makes for better cancer treatments

16 hours ago

A South Australian invention, responsible for unboiling an egg, has been used to produce a four-fold increase in efficacy of carboplatin, a commonly used drug for ovarian, lung and other cancer. ...

Using healthy skin to identify cancer's origins

May 21, 2015

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and de ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
4 / 5 (2) May 13, 2008
And if you believe that big pharma and the industrial medical cartel will allow such a drug to be marketed, or even make it to phase I testing, I've got a bridge in Brooklyn you may be interested in buying.
E_L_Earnhardt
not rated yet May 14, 2008
a TABLET AFTER EVERY MAMMAGRAM MIGHT HELP!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.